Literature DB >> 16651279

Interferon-alpha treatment of molluscum contagiosum in a patient with hyperimmunoglobulin E syndrome.

Sara Sebnem Kilic1, Fatih Kilicbay.   

Abstract

We report widely disseminated molluscum contagiosum that occurred in a 9-year-old boy secondary to hyperimmunoglobulin E syndrome, a primary immunodeficiency disorder. Cutaneous examination revealed numerous, widespread, skin-colored to translucent, firm, umbilicated papules of varying sizes. They were distributed throughout the perineal and gluteal areas and bilaterally over his lower limbs. A biopsy specimen from his skin lesion demonstrated lobulated epidermal growth that consisted of keratinocytes with large intracytoplasmic eosinophilic inclusion bodies and a central crater. These findings were consistent with the diagnosis of molluscum contagiosum. Many treatments for his skin lesions were ineffective, including physical destruction or manual extrusion of the lesions; cryotherapy; curettage; and topical therapies with phenol, trichloroacetic acid, and imiquimod. The patient was treated successfully with subcutaneous interferon-alpha for 6 months without any adverse effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651279     DOI: 10.1542/peds.2005-2706

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Do you know this syndrome?

Authors:  Alexandre Moretti de Lima; Vitor Arantes Sperandio; Sheila Pereira da Rocha; Beatriz Medeiros de Ribeiro; Carmelia Matos Santiago Reis
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

2.  Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).

Authors:  Wen-I Lee; Jing-Long Huang; Shy-Jae Lin; Kuo-Wei Yeh; Li-Chen Chen; Meng-Ying Hsieh; Yhu-Chering Huang; Ho-Chang Kuo; Kunder D Yang; Hong-Ren Yu; Tang-Her Jaing; Chih-Hsun Yang
Journal:  J Clin Immunol       Date:  2010-12-01       Impact factor: 8.542

Review 3.  Use of cytokine therapy in primary immunodeficiency.

Authors:  Sumita Roy-Ghanta; Jordan S Orange
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 10.817

Review 4.  Recurrent and Sustained Viral Infections in Primary Immunodeficiencies.

Authors:  Melanie A Ruffner; Kathleen E Sullivan; Sarah E Henrickson
Journal:  Front Immunol       Date:  2017-06-19       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.